Previous close | 0.1250 |
Open | 0.1100 |
Bid | 0.1050 x 197574900 |
Ask | 0.1100 x 26031200 |
Day's range | 0.1000 - 0.1200 |
52-week range | 0.1000 - 0.2500 |
Volume | |
Avg. volume | 201,763 |
Market cap | 25.343M |
Beta (5Y monthly) | 1.95 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.0800 |
Earnings date | 30 Oct 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Organizational Chart Executive Roles and Responsibilities BELLEVUE, Wash., May 03, 2023 (GLOBE NEWSWIRE) -- Medical device and consumer electronics manufacturer, Nuheara Limited (ASX:NUH) (Company or Nuheara) is pleased to announce key executive appointments and associated restructure of its senior executive team. These changes cement the Company’s transformation over the past two years into a medical device manufacturer of world-first US FDA-cleared Over The Counter (OTC) Hearing Aids. A key pa
Nuheara ( ASX:NUH ) First Half 2023 Results Key Financial Results Revenue: AU$765.6k (down 74% from 1H 2022). Net loss...
Increases points of sale by 3000 US Ear Nose and Throat & Audiology ClinicsBellevue, Wash., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Nuheara announces the commercial availability of its HP Hearing PRO self-fitting, air-conduction, OTC hearing aid through Fuel Medical member clinics in the US. Nuheara’s HP Hearing PRO is the first product cleared through the FDA’s 510(k) process for both 874.3325 self-fitting and the 800.30 OTC hearing aid classifications under a new product classification code “QUH”. T